Genetically Engineered Glucocorticoid Receptor Knock Out Virus-Specific CTL Lines
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically Engineered Glucocorticoid Receptor Knock Out Virus-Specific CTL Lines, covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients [Phase 1]